Ainos, Inc. (AIMDW)
| Market Cap | 11.12M +32.2% |
| Revenue (ttm) | 18,111 -82.9% |
| Net Income | -13.94M |
| EPS | -2.80 |
| Shares Out | 8.52M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 0.0804 |
| Previous Close | n/a |
| Day's Range | 0.0779 - 0.0804 |
| 52-Week Range | n/a |
| Beta | 2.31 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 13, 2026 |
About AIMDW
Ainos, Inc., a dual-platform company, focusing artificial intelligence–based smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing industries; as well as senior care and women’s health sectors. In addition, it develops VELDONA, a low-dose oral interferon platform for human and animal he... [Read more]
News
VASRO Research Highlights Ainos AI Nose Commercialization Progress and Semiconductor Industry Shift Toward AI-Driven Environmental Intelligence
HOUSTON, TX / ACCESS Newswire / May 20, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today highlighted a new research update published by VASRO GmbH discussing AI Nose, th...
Ainos Reports First Quarter 2026 Financial Results and Highlights Smell AI Execution Across Semiconductors and Healthcare Infrastructure Markets
HOUSTON, TX / ACCESS Newswire / May 13, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced financial results for the first quarter ended March 31, 2026 and provi...
Ainos Earnings release: Q1 2026
Ainos released its Q1 2026 earnings on May 13, 2026, summarizing the period's financial results.
Ainos Quarterly report: Q1 2026
Ainos has published its Q1 2026 quarterly earnings report on May 13, 2026.
Ainos updates standard industrial classification code to reflect Smell AI
Ainos (AIMD) announced that it updated its Standard Industrial Classification code from SIC 2834 – Pharmaceutical Preparations to SIC 3577 – Computer Peripheral Equipment, NEC. We believe the updated ...
Ainos Updates Standard Industrial Classification Code to Reflect Smell AI Business Focus
Updated classification reflects Ainos' transition toward AI-powered scent intelligence commercialization HOUSTON, TX / ACCESS Newswire / May 11, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos"...
Ainos highlights ‘continued expansion’ of Smell AI deployments
Ainos (AIMD) highlighted the continued expansion of its Smell AI deployments, powered by AI Nose, across semiconductor, robotics, and healthcare infrastructure, highlighted by recent third-party resea...
VASRO: Ainos Expands Smell AI from Industrials into Healthcare Infrastructure, Reinforcing AI Infrastructure Positioning and Multi-Vertical Scalability
2026 Identified as a Key Scale-Up Phase with Expanding Market Verticals and Accelerating Data Flywheel HOUSTON, TX / ACCESS Newswire / April 17, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) today hi...
Ainos announces partnership with MacKay Memorial Hospital, Topco Scientific
Ainos (AIMD) announced a partnership with MacKay Memorial Hospital and Topco Scientific to deploy its AI Nose technology across high-risk hospital environments. The collaboration aims to expand Ainos’...
Ainos, MacKay Memorial Hospital and Topco Scientific Partner to Advance Smell AI Deployment in High-Risk Hospital Environments
Expands AI Nose platform from industrial safety into clinical infrastructure HOUSTON, TX / ACCESS Newswire / April 8, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) today announced a partnership with ...
Ainos Slides: Investor presentation
Ainos has posted slides in relation to its latest quarterly earnings report, which was published on April 6, 2026.
VASRO Research Highlights Ainos' Smell AI Commercial Progress and 2026 Deployment Momentum
Report highlights transition to deployment-driven growth, with visible semiconductor rollout and early customer-backed revenue Smell AI, powered by AI Nose, is emerging as a new AI perception layer, s...
Ainos reports FY25 revenue $124,157 vs. $20,729 last year
“2025 marked our transition in expanding AI Nose’s commercial focus from healthcare into industrial markets. Our focus in 2025 was building the platform and partnerships required for scale,” said Eddy...
Ainos CFO says maintained ‘disciplined financial approach’ in FY25
“In 2025 we maintained a disciplined financial approach while supporting SmellTech platform’s scale. Total revenue increased approximately 499% year over year, mainly reflecting progress in our AI Nos...
Ainos Reports Full Year 2025 Financial Results and Highlights Commercial Momentum Entering 2026
AI Nose drove 499% revenue growth in 2025, with gross margin turning positive to 82.9% 2025 partnerships now driving scaled AI Nose deployments in 2026, supported by disciplined financing HOUSTON, TX ...
Ainos Earnings release: Q4 2025
Ainos released its Q4 2025 earnings on March 30, 2026, summarizing the period's financial results.
Ainos Annual report: Q4 2025
Ainos has published its Q4 2025 annual report on March 30, 2026.
Ainos says WSJ highlights emerging ‘Smell AI’ in article
Ainos (AIMD) highlighted its inclusion in The Wall Street Journal article “The E-Nose Knows: AI Learns to Smell,” which underscores the emergence of AI capable of sensing and interpreting smell-expand...
The Wall Street Journal Highlights Emerging "Smell AI" - Ainos Advances Commercial Deployment in Semiconductor Environments
As AI expands beyond vision and language, Ainos advances commercial deployment of AI Nose in industrial environments-positioning the Company at the forefront of this emerging category HOUSTON, TX / AC...
Water Tower Research Highlights Ainos' Scaling Momentum Across Semiconductor Value Chain
AI Nose deployment into front-end wafer fabrication facilities marks a critical validation step in semiconductor manufacturing environments Recurring revenue visibility strengthens as AI Nose deployme...
Ainos announces continued validation testing of AI Nose platform
Ainos (AIMD), announced continued validation testing of its AI Nose platform within advanced semiconductor front-end wafer fabrication environments. As part of this qualification phase, Ainos plans to...
Ainos Expands AI Nose Validation in Front-End Wafer Fabs with 200 Targeted Deployments in Q1 2026
Company affirms execution milestones, subscription activation roadmap, and long-term infrastructure vision remain unchanged despite market volatility HOUSTON, TEXAS / ACCESS Newswire / March 9, 2026 /...
Ainos CEO says AI Nose platform transitioning into industrial deployment
Ainos (AIMD) issued a letter from Chairman, President and CEO Eddy Tsai, which read in part, “I’m proud to share that the AI Nose platform is transitioning from validation-stage pilots…
Ainos Issues Shareholder Letter on Phased AI Nose Deployment of Up to 20,000 Systems and Scalable Recurring Revenue Opportunity
HOUSTON, TEXAS / ACCESS Newswire / March 2, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today issued the following letter from Chairman, President and Chief Executive Off...
Ainos activates industrial deployment roadmap of up to 20,000 units
Ainos (AIMD) announced the activation of a phased industrial deployment roadmap under a strategic framework that contemplates the installation of up to 20,000 AI Nose units within semiconductor manufa...